Literature DB >> 9802493

Single-voxel proton MR spectroscopy of nonneoplastic brain lesions suggestive of a neoplasm.

H G Krouwer1, T A Kim, S D Rand, R W Prost, V M Haughton, K C Ho, S S Jaradeh, G A Meyer, K A Blindauer, J F Cusick, G L Morris, P R Walsh.   

Abstract

BACKGROUND AND
PURPOSE: MR spectroscopy is used to characterize biochemical components of normal and abnormal brain tissue. We sought to evaluate common histologic findings in a diverse group of nonneoplastic diseases in patients with in vivo MR spectroscopic profiles suggestive of a CNS neoplasm.
METHODS: During a 2-year period, 241 patients with suspected neoplastic CNS lesions detected on MR images were studied with MR spectroscopy. Of these, five patients with a nonneoplastic diagnosis were identified retrospectively; a sixth patient without tissue diagnosis was added. MR spectroscopic findings consistent with a neoplasm included elevated choline and decreased N-acetylaspartate and creatine, with or without detectable mobile lipid and lactate peaks.
RESULTS: The histologic specimens in all five patients for whom tissue diagnoses were available showed significant WBC infiltrates, with both interstitial and perivascular accumulations of lymphocytes, macrophages, histiocytes, and (in one case) plasma cells. Reactive astrogliosis was also prominent in most tissue samples. This cellular immune response was an integral component of the underlying disorder in these patients, including fulminant demyelination in two patients, human herpesvirus 6 encephalitis in one patient, organizing hematoma from a small arteriovenous malformation in one patient, and inflammatory pseudotumor in one patient. Although no histologic data were available in the sixth patient, neoplasm was considered unlikely on the basis of ongoing clinical and neuroradiologic improvement without specific therapy.
CONCLUSION: Nonneoplastic disease processes in the CNS may elicit a reactive proliferation of cellular elements of the immune system and of glial tissue that is associated with MR spectroscopic profiles indistinguishable from CNS neoplasms with current in vivo MR spectroscopic techniques. Such false-positive findings substantiate the need for histologic examination of tissue as the standard of reference for the diagnosis of intracranial mass lesions.

Entities:  

Mesh:

Year:  1998        PMID: 9802493      PMCID: PMC8337475     

Source DB:  PubMed          Journal:  AJNR Am J Neuroradiol        ISSN: 0195-6108            Impact factor:   3.825


  18 in total

1.  Differentiation of tuberculous from pyogenic brain abscesses with in vivo proton MR spectroscopy and magnetization transfer MR imaging.

Authors:  R K Gupta; D K Vatsal; N Husain; S Chawla; K N Prasad; R Roy; R Kumar; D Jha; M Husain
Journal:  AJNR Am J Neuroradiol       Date:  2001-09       Impact factor: 3.825

Review 2.  Three-dimensional magnetic resonance spectroscopic imaging of brain and prostate cancer.

Authors:  J Kurhanewicz; D B Vigneron; S J Nelson
Journal:  Neoplasia       Date:  2000 Jan-Apr       Impact factor: 5.715

Review 3.  Biologic imaging of head and neck cancer: the present and the future.

Authors:  A Srinivasan; S Mohan; S K Mukherji
Journal:  AJNR Am J Neuroradiol       Date:  2011-12-22       Impact factor: 3.825

Review 4.  Inflammatory pseudotumor of the cavernous sinus and skull base.

Authors:  Todd McCall; Daniel R Fassett; George Lyons; William T Couldwell
Journal:  Neurosurg Rev       Date:  2006-03-25       Impact factor: 3.042

5.  Characterisation of musculoskeletal tumours by multivoxel proton MR spectroscopy.

Authors:  Ruchi S Patni; Deb K Boruah; Shantiranjan Sanyal; Bidyut B Gogoi; Maninder Patni; Rosy Khandelia; Nripen Gogoi
Journal:  Skeletal Radiol       Date:  2017-02-11       Impact factor: 2.199

6.  Discrepant lesion size estimated on T1- and fat-suppressed T2-weighted MRI: diagnostic value for differentiation between inflammatory pseudotumor and carcinoma of the nasopharynx.

Authors:  Hye Na Jung; Hyung Jin Kim; Yi Kyung Kim; Mina Song; Ha Yeon Kim; Kyung Min Park; Jihoon Cha; Sung Tae Kim
Journal:  Diagn Interv Radiol       Date:  2017 May-Jun       Impact factor: 2.630

7.  In vivo characterisation of soft tissue tumours by 1.5-T proton MR spectroscopy.

Authors:  F Russo; S Mazzetti; G Grignani; G De Rosa; M Aglietta; G C Anselmetti; M Stasi; D Regge
Journal:  Eur Radiol       Date:  2011-12-04       Impact factor: 5.315

8.  Discrimination between neoplastic and nonneoplastic brain lesions by use of proton MR spectroscopy: the limits of accuracy with a logistic regression model.

Authors:  J Butzen; R Prost; V Chetty; K Donahue; R Neppl; W Bowen; S J Li; V Haughton; L Mark; T Kim; W Mueller; G Meyer; H Krouwer; S Rand
Journal:  AJNR Am J Neuroradiol       Date:  2000-08       Impact factor: 3.825

9.  Proton MR spectroscopic evaluation of suspicious brain lesions after stereotactic radiotherapy.

Authors:  H P Schlemmer; P Bachert; K K Herfarth; I Zuna; J Debus; G van Kaick
Journal:  AJNR Am J Neuroradiol       Date:  2001-08       Impact factor: 3.825

10.  Proton MR spectroscopy of gliomatosis cerebri: case report of elevated myoinositol with normal choline levels.

Authors:  Efrat Saraf-Lavi; Brian C Bowen; Pradip M Pattany; Evelyn M L Sklar; James B Murdoch; Carol K Petito
Journal:  AJNR Am J Neuroradiol       Date:  2003-05       Impact factor: 3.825

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.